Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Zinc
100%
Breast Cancer
100%
Malignant Phenotype
100%
Subtype-specific
100%
Zinc Pool
100%
Bioavailable Zinc
100%
ZnT2
63%
MDA-MB-231 Cells
54%
Dysregulation
27%
Zinc Transporter
27%
Overexpression
18%
HyPer
18%
Breast Cancer Cell Lines
18%
T47D
18%
Human Breast Tumor
18%
FluoZin-3
18%
MCF10A Cells
18%
Zinc Distribution
18%
Atomic Absorption Spectrometry
9%
Flow Cytometry
9%
Microarray
9%
Quantitative PCR
9%
Immunoblotting
9%
Functional Consequences
9%
Gene Expression Profiling
9%
Apoptosis
9%
Proteasomal Degradation
9%
Response to Therapy
9%
Human Tumors
9%
MTT Assay
9%
Relative Abundance
9%
Evenly Distributed
9%
Invasiveness
9%
MDA-MB-231
9%
Breast Tumor
9%
Functional Relevance
9%
Boyden Chamber
9%
Mammary Epithelium
9%
Metallothionein
9%
Tumor Cell Lines
9%
Breast Tumor Cells
9%
Transporter Expression
9%
Metastatic Potential
9%
Nonmalignant
9%
Hyperaccumulation
9%
Phenotypic Characteristics
9%
Breast Tumor Tissues
9%
Distinct Subtypes
9%
Subcellular Compartments
9%
Zinc Content
9%
Zinc Accumulation
9%
Basal-like Tumors
9%
Malignant Breast Tumor
9%
Breast Cells
9%
Medicine and Dentistry
Breast Cancer
100%
Breast Tumor
100%
Cell Line
66%
Zinc Transporter
50%
Neoplasm
33%
Breast Cancer Cell Line
33%
Cell Cycle
33%
X-Ray Fluorescence Spectroscopy
33%
Real Time Polymerase Chain Reaction
16%
Flow Cytometry
16%
Programmed Cell Death
16%
Metallothionein
16%
Immunoblotting
16%
Mammary Epithelium
16%
Gene Expression Profiling
16%
Metastasis Potential
16%
Atomic Absorption Spectrometry
16%
MTT Assay
16%
Breast Cell
16%
Cellular Compartment
16%
Hyperaccumulation
16%
Immunology and Microbiology
Cell Line
100%
Breast Cancer Cell Line
50%
Cell Cycle
50%
X-Ray Fluorescence Spectroscopy
50%
Western Blot
25%
Real Time Polymerase Chain Reaction
25%
Atomic Absorption Spectroscopy
25%
Gene Expression Assay
25%
Programmed Cell Death
25%
Metallothionein
25%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Breast Tumor
100%
Zinc Transporter
50%
Neoplasm
33%
Flow Cytometry
16%
Western Blot
16%
Metastasis Potential
16%
Metallothionein
16%
Hyperaccumulation
16%
Biochemistry, Genetics and Molecular Biology
X Ray Fluorescence
100%
Inductively Coupled Plasma Mass Spectrometry
50%